893 results on '"Fujisawa, Yasuhiro"'
Search Results
2. Reconstruction methods for and cosmetic evaluation of external nasal tumour resections: flap versus graft
3. Highly concentrated trehalose induces prohealing senescence-like state in fibroblasts via CDKN1A/p21
4. Analyzing the relationship between the efficacy of first-line immune checkpoint inhibitors and cumulative sun damage in Japanese patients with advanced BRAF wild-type nonacral cutaneous melanoma: A retrospective real-world, multicenter study
5. Phase II, multicenter study of plasminogen activator inhibitor-1 inhibitor (TM5614) plus nivolumab for treating anti-PD-1 antibody-refractory malignant melanoma: TM5614-MM trial
6. 広範囲の毛細血管拡張から疑い診断しえた血管内大細胞型 B 細胞リンパ腫の 1 例
7. In memoriam: Thomas Fletcher Tedder, PhD (1956-2024)
8. Rainfall-Induced Lahar Occurrences Shortly After Eruptions and Its Initiation Processes in Japan
9. F-18 FDG PET Tests in Skin Cancer Including Malignant Melanoma
10. Loricrin and NRF2 Coordinate Cornification
11. Differential Involvement of Programmed Cell Death Ligands in Skin Immune Responses
12. Three-Year Analysis of Adjuvant Therapy in Postoperative Melanoma including Acral and Mucosal Subtypes.
13. Classification of large-scale image database of various skin diseases using deep learning
14. Long‐term follow‐up results from KEYNOTE‐041: Phase 1b study of pembrolizumab in Japanese patients with advanced melanoma
15. Anatomic Subtype Differences in Extramammary Paget Disease
16. Soluble PD‐L1 predicts tumor response and immune‐related adverse events in patients with advanced melanoma treated with anti–PD‐1 antibodies
17. Adult epidermal nevus syndrome with hypophosphatemic osteomalacia treated with burosumab: a case study and literature review
18. Preface to the Journal of Dermatology special issue: The changing landscape of melanoma treatment
19. Factors for Improving Diagnosis of Skin Tumors
20. Serum lactate dehydrogenase level as a possible predictor of treatment preference in psoriasis
21. The liposome of trehalose dimycolate extracted from M. bovis BCG induces antitumor immunity via the activation of dendritic cells and CD8+ T cells
22. IFN-γ–Stimulated Apoptotic Keratinocytes Promote Sclerodermatous Changes in Chronic Graft-Versus-Host Disease
23. Langerhans Cells Suppress CD8+ T Cells In Situ during Mucocutaneous Acute Graft-Versus-Host Disease
24. Deep Neural Network for Early Image Diagnosis of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis
25. Prediction of the invasive level of basal cell carcinomas in the facial area: Analysis of 718 Japanese cases
26. Cutaneous lymphoma in Japan, 2012–2017: A nationwide study
27. Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Regulates Epidermal Keratinization under Psoriatic Skin Inflammation
28. Cutaneous arteritis combined with antiphospholipid syndrome associated with the use of immune checkpoint inhibitors in a patient with a metastatic lung adenocarcinoma
29. Efficacy and safety of TM5614 in combination with paclitaxel in the treatment of paclitaxel‐resistant cutaneous angiosarcoma: Phase II study protocol
30. Skin T cells maintain their diversity and functionality in the elderly
31. Classification of 3097 patients from the Japanese melanoma study database using the American joint committee on cancer eighth edition cancer staging system
32. Rainfall-Induced Lahar Occurrences Shortly After Eruptions and Its Initiation Processes in Japan
33. F-18 FDG PET Tests in Skin Cancer Including Malignant Melanoma
34. A protocol for phase II study investigating the safety and efficacy of TM5614 in combination with nivolumab in the treatment of unresectable malignant melanoma
35. Retrospective analysis of adjuvant therapy using dabrafenib plus trametinib in Japanese patients with advanced melanoma: analysis of 36 cases
36. Nation-wide survey of advanced non-melanoma skin cancers treated at dermatology departments in Japan
37. Adverse events associated with postoperative outcomes of adjuvant anti‐PD‐1 antibody therapy in both acral and non‐acral cutaneous melanomas: A multicenter, observational, post hoc analysis study.
38. Efficacy and safety of TM5614 in combination with paclitaxel in the treatment of paclitaxel‐resistant cutaneous angiosarcoma: Phase II study protocol.
39. Systemic therapy for Asian patients with advanced BRAF V600‐mutant melanoma in a real‐world setting: A multi‐center retrospective study in Japan (B‐CHECK‐RWD study)
40. Adverse events associated with postoperative outcomes of adjuvant anti‐PD‐1 antibody therapy in both acral and non‐acral cutaneous melanomas: A multicenter, observational, post hoc analysis study
41. Reconstruction using a vertical “sagging cheek” advancement flap for defects following full-thickness excision of non-melanoma skin cancer in the elderly: a case series
42. Surgical damage to the lymphatic system promotes tumor growth via impaired adaptive immune response
43. Retrospective study of advanced melanoma patients treated with ipilimumab after nivolumab: Analysis of 60 Japanese patients
44. Activation of CD8 T cells accelerates anti-PD-1 antibody-induced psoriasis-like dermatitis through IL-6
45. Fluctuations in routine blood count might signal severe immune-related adverse events in melanoma patients treated with nivolumab
46. Eribulin mesylate exerts antitumor effects via CD103
47. Postoperative adjuvant therapy for120 melanoma patients, including acral and mucosal subtypes: A multicenter, observational study of two-year follow-up results
48. Combined use of nivolumab and ipilimumab among Japanese melanoma patients: Multi-center, retrospective study of 111 cases
49. SPOP is essential for DNA replication licensing through maintaining translation of CDT1 and CDC6 in HaCaT cells
50. Increased serum CCL26 level is a potential biomarker for the effectiveness of anti-PD1 antibodies in patients with advanced melanoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.